WealthTrust Axiom’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-16,396
| Closed | -$384 | – | 268 |
|
2025
Q1 | $384 | Hold |
16,396
| – | – | ﹤0.01% | 255 |
|
2024
Q4 | $2.64K | Hold |
16,396
| – | – | ﹤0.01% | 254 |
|
2024
Q3 | $3.79K | Buy |
16,396
+5,000
| +44% | +$1.16K | ﹤0.01% | 263 |
|
2024
Q2 | $6.2K | Hold |
11,396
| – | – | ﹤0.01% | 255 |
|
2024
Q1 | $11.6K | Buy |
+11,396
| New | +$11.6K | ﹤0.01% | 261 |
|